MediPal Holdings Corporation

$ 2 591.50 2.15 %

Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.

CEO: Shuichi Watanabe - https://www.medipal.co.jp

Price objectif

-

Recommandation

-

DCF

$ 9 283.57

Loading data...

7459.T vs S&P500

Loading data...

No data available.

Quick ratio

1.11

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

12.55

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

206.54

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

6.72 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

4.04 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

5.17

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.00

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.00

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
2.95 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.27 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.00 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.